Human placental trophoblast as an in vitro model for tumor progression

Canadian Journal of Physiology and Pharmacology

Volumn 80, Issue 2, 2002, Pages 142-149

  Lala, P K ^a   Lee, B P ^a   Xu, G ^a   Chakraborty, C ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Choriocarcinoma; Fibronectin; IGFBP 5; TGF ; Trophoblast

Indexed keywords

CONNEXIN 43; CYTOKERATIN 18; CYTOKERATIN 7; CYTOKERATIN 8; DNA POLYMERASE; FIBRONECTIN; HLA G ANTIGEN; HUMAN PLACENTA LACTOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; NUCLEOPORIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 5; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR III; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; CANCER CELL; CELL COMMUNICATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHORIOCARCINOMA; DOWN REGULATION; EXTRACELLULAR MATRIX; GAP JUNCTION; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; MICROENVIRONMENT; MOLECULAR MECHANICS; NONHUMAN; PHENOTYPE; PLACENTA; PRIORITY JOURNAL; TROPHOBLAST; TUMOR GROWTH;

CELL LINE; CHORIOCARCINOMA; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; PLACENTA; PRECANCEROUS CONDITIONS; PREGNANCY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TROPHOBLASTS; TUMOR CELLS, CULTURED;

EID: 0036203641     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y02-006     Document Type: Article

References (60)

1. Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration
2. Fibronectin and integrins in invasion and metastasis
3. Insulin-like growth factor binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor
4. Proteolysis in the penetration phase of the implantation process
5. P13-K/AKT regulation of NF-κB signaling events in suppression of TNF-induced apoptosis
6. Inhibition of TGF-β3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies
7. Regulation of human trophoblast migration and invasiveness
8. Lack of transforming growth factor-beta 1 expression in benign skin tumors of p53 null mice is prognostic for high risk of malignant conversion
9. Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-β-induced physical and functional interactions between samds and Sp1
10. Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction
11. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumor cells
12. Development of resistance mechanisms to the growth inhibitory effects of transforming growth factor-β during tumor progression
13. Parent cells for trophoblast hybridization I: Isolation of extravillous trophoblast cells from human term chorionic laeve
14. Insulin-like growth-factor-binding protein 1 stimulates human trophoblast migration by signaling through α5β1 integrin via mitogen-activated protein kinase pathway
15. Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion
16. Effect of transforming growth factor β in the plasminogen activator system in cultures first trimester human cytotrophoblast
17. Mechanisms of control of trophoblast invasion in situ
18. Mechanisms of placental invasion of the uterus and their control
19. Localization of transforming growth factor-β at the human fetal-maternal interface: Role in trophoblast growth and differentiation
20. Establishment and characterization of first t rimester human trophoblast cells with extended lifespan
21. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-β
22. Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-1
23. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture
24. Functional role of cell surface integrins on human trophoblast cell migration: Regulation by TGFβ IGF-II and IGFBP-1
25. Characteristics of trophoblast cells migrating from first trimester chorionic villus explants and propagated in culture
26. Extravillous trophoblast in the human placenta. A review
27. SV40 tag transformation of the normal invasive trophoblast results in a premalignant phenotype. I. Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGF-β
28. SV40 tag transformation of the normal invasive trophoblast results in a premalignant phenotype. II. Changes in gap junctional intercellular communication
29. Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in trophoblast cell line
30. Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells
31. Insulin-like growth factors, their regulation of glucose and amino acid transport in placental trophoblasts isolated from first-trimester human trophoblast
32. The morphology, biology, and pathology of intermediate trophoblast. A look back to the present
33. Mechanisms of trophoblast invasiveness and their control: The role of proteases and protease inhibitors cancer
34. Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue
35. Control mechanisms in human trophoblast proliferation and invasiveness: Their derangement during trophoblastic tumor progression
36. Differential gene expression in premalignant human trophoblast: Role of IGFB-5
37. Partial characterization of an immortalized human trophoblast cell line, TCL-1 which possesses a CSF-1 autocrine loop
38. Identification and cloning of two histone fold motif-containing subunits of Hela DNA polymerase ε
39. Dynein intermediate chain mediated dynein-dynactin interaction is required for interphase microtubule organization and centrosome replication and separation in Dictyostelium
40. TGF-β signal transduction
41. Controlling TGF-β signalling
42. Regulatory mechanisms for transforming growth factor β as an autocrine inhibitor in human hepatocellular carcinoma: Implications for roles of Smads in its growth
43. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK
44. Dominant-negative Smad3 interferes with transcriptional activation by multiple agonists
45. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β
46. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer
47. Acquisition of TGF-β1 resistance, an important progression factor in human renal cell carcinoma
48. Identification of differentially expressed genes in chemically induced skin tumours
49. Expresssion of Mel-CAM in implantation site intermediate trophoblast cell lie, IST-1, limits its migration on uterine smooth muscle cells
50. Disruption of TGF beta signaling pathways in human pancreatic cancer cells
51. Blocking Sp 1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: Implications for the treatment of tissue fibrosis
52. Chromokinesin: A DNA-binding, kinesin-like nuclear protein
53. Expression of TGFβ signaling genes in the normal, premalignant and malignant human trophoblast: Loss of Smad 3 in choriocarcinoma cells
54. Normal nonmetastatic human trophoblast cells share in vitro invasion properties of malignant cells
55. Characterization of pure human first-trimester cytotrophoblast cells in long-term culture: Growth pattern, markers and hormone production
56. Basement membrane invasion by first trimester human trophoblast: Requirement for branched complex-type asn-linked oligosaccharides
57. Heterogeneities in the biological and biochemical functions of Smad 2 and Smad 4 mutants naturally occurring in human lung cancers
58. Susceptibility of MHC class 1 expressing extravillous trophoblast cell lines to killing by natural killer cells
59. Receptor-associated Mad homologues synergize as effectors of the TGF-β response